Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection
Public ClinicalTrials.gov record NCT02299570. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2B Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study Demonstrating the Efficacy and Safety of Rebiotix RBX2660 (Microbiota Suspension) for the Treatment of Recurrent Clostridium Difficile Infection
Study identification
- NCT ID
- NCT02299570
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Rebiotix Inc.
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Interventions
- RBX2660 (microbiota suspension) Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2014
- Primary completion
- Dec 31, 2015
- Completion
- Dec 31, 2017
- Last update posted
- Jan 14, 2021
2014 – 2018
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Arizona | Phoenix | Arizona | 85054 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| Borland-Groover Clinic | Jacksonville | Florida | 32256 | — |
| Grand Teton Research Group | Idaho Falls | Idaho | 83404 | — |
| Loyola University Chicago | Chicago | Illinois | 60153 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Infectious Diseases of Indiana | Indianapolis | Indiana | 46260 | — |
| Chevy Chase Clinical Research | Chevy Chase | Maryland | 20815 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Mayo Clinic Minnesota | Rochester | Minnesota | 55905 | — |
| Regions Hospital | Saint Paul | Minnesota | 55101 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| New York Hospital Queens | Flushing | New York | 11355 | — |
| New York-Presbyterian Hospital/Weill Cornell Medical College | New York | New York | 10065 | — |
| Gastroenterology Group of Rochester | Rochester | New York | 14618 | — |
| Sanford Health | Fargo | North Dakota | 58122 | — |
| Louis Stokes Cleveland VA Medical Center | Cleveland | Ohio | 44106 | — |
| Regional Infectious Diseases and Infusion Center | Lima | Ohio | 45801 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02299570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 14, 2021 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02299570 live on ClinicalTrials.gov.